C2N Diagnostics logo

C2N Diagnostics

Fierce Medtech named C2N one of its Fierce 15 for 2020; "one of the most promising private companies in the industry.”

92 employees · est. 2007 · United States

VS
PetDx logo

PetDx

The Liquid Biopsy Company for Pets ™

13 employees · est. 2019 · San Diego, United States

C2N Diagnostics is the older company (2007 vs 2019); C2N Diagnostics is the larger of the two.

Side-by-Side Comparison

C2N Diagnostics PetDx
Founded
2007 older 2019
Headquarters
United States San Diego, United States
Employees
92 larger 13
Industry
Biotechnology Not tracked yet
Funding Stage
Corporate Round Series B
Total Funding
$52.20M $71.80M
Funding Rounds
4 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Medtech, Diagnostics, Therapeutic Discovery, Neurological Disorders, Blood Tests, Alzheimer’s Disease, Precision Medicine, Mass Spectrometry, Health Care, FDA Breakthrough Device, CE Mark, Protein Diagnostics, Neurodegeneration, Research And Development Liquid Biopsy, Molecular Diagnostics, Genomics, Pet Health, OncoK9, Cancer Detection, NGS Technology, Bioinformatic Algorithms, Veterinarians, Canine Patients
Website
c2ndiagnostics.com petdx.com
C2N Diagnostics logo

About C2N Diagnostics

C2N Diagnostics, established in 2007 and headquartered in the United States, is a biotechnology startup making significant strides in the medical industry. The company's dedication to innovation and excellence has been acknowledged by Fierce Medtech, which named C2N one of its Fierce 15 for 2020, re...

PetDx logo

About PetDx

PetDx, known as The Liquid Biopsy Company for Pets™, is a promising San Diego-based startup revolutionizing the pet health industry. The company specializes in molecular diagnostics, leveraging the power of genomics to enhance pet care. A standout in their offerings is OncoK9®, a pioneering multi-ca...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at C2N Diagnostics and PetDx — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at C2N Diagnostics and PetDx — by email.

Frequently Asked Questions

C2N Diagnostics — Fierce Medtech named C2N one of its Fierce 15 for 2020; "one of the most promising private companies in the industry.”. PetDx — The Liquid Biopsy Company for Pets ™. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
C2N Diagnostics has raised $52.20M while PetDx has raised $71.80M.
C2N Diagnostics and PetDx operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare C2N Diagnostics with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy